Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells.
Ontology highlight
ABSTRACT: Members of the bromodomain and extra-C terminal (BET) domain protein family and the histone deacetylase (HDAC) enzyme family regulate the expression of important oncogenes and tumor suppressor genes. Here we show that the BET inhibitor JQ1 inhibits proliferation and induces apoptosis of both triple negative and estrogen receptor positive breast cancer cells. Consistent with the critical role of histone acetylation in the regulation of gene expression, treatment with JQ1 or the HDAC inhibitor mocetinostat was associated with global changes in gene expression resulting in suppression of genes involved in cell-cycle regulation. Combining JQ1 with mocetinostat, further decreased cell viability. This synergistic effect was associated with increased suppression of genes essential for cell-cycle
SUBMITTER: Borbely G
PROVIDER: S-EPMC4741790 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA